| Literature DB >> 32686483 |
Zhong Lin1, Dong Li2, Gang Zhai2, Yu Wang2, Liang Wen2, Xiao Xia Ding2, Feng Hua Wang3, Yu Dou2, Cong Xie2, Yuan Bo Liang1.
Abstract
PURPOSE: To investigate the association between high myopia and diabetic retinopathy, and its possible mechanism, in a northeastern Chinese population with type 2 diabetic mellitus.Entities:
Keywords: High myopia; central retinal vein; diabetic retinopathy
Mesh:
Year: 2020 PMID: 32686483 PMCID: PMC7510364 DOI: 10.1177/1479164120940988
Source DB: PubMed Journal: Diab Vasc Dis Res ISSN: 1479-1641 Impact factor: 3.291
Characteristics of subjects with and without high myopia.
| Absence of high myopia (n = 1715) | High myopia (n = 102) | ||
|---|---|---|---|
| Age (years) | 61.4 ± 8.5 | 59.5 ± 9.9 | 0.06 |
| Male, n (%) | 725 (42.3) | 26 (25.5) | <0.001 |
| Spherical equivalent (diopter) | 0.18 ± 1.55 | −9.33 ± 4.96 | <0.001 |
| Duration of diabetes (years) | 7.6 ± 5.8 | 6.5 ± 4.9 | 0.03 |
| FPG (mmol/L) | 9.3 ± 3.4 | 9.6 ± 3.9 | 0.41 |
| HbA1C (%) | 7.8 ± 2.0 | 7.8 ± 1.9 | 0.96 |
| BMI (kg/m2) | 26.4 ± 3.4 | 26.5 ± 3.3 | 0.80 |
| Waist/hip ratio | 0.96 ± 0.06 | 0.97 ± 0.06 | 0.48 |
| SBP (mmHg) | 147.1 ± 23.2 | 149.7 ± 24.1 | 0.27 |
| DBP (mmHg) | 77.3 ± 11.2 | 79.3 ± 13.4 | 0.14 |
| Serum creatinine (μmol/L) | 84.6 ± 19.6 | 83.0 ± 17.0 | 0.42 |
| BUN (mmol/L) | 6.3 ± 3.3 | 5.9 ± 1.8 | 0.047 |
| BUA (μmol/L) | 309.6 ± 88.2 | 312.7 ± 82.6 | 0.73 |
| Total cholesterol (mmol/L) | 5.5 ± 1.3 | 5.5 ± 1.1 | 0.94 |
| Total triglycerides (mmol/L) | 2.2 ± 1.7 | 2.1 ± 1.6 | 0.56 |
| LDL (mmol/L) | 3.2 ± 0.9 | 3.2 ± 0.8 | 0.50 |
| HDL (mmol/L) | 1.5 ± 0.4 | 1.5 ± 0.4 | 0.36 |
| Current smoker, n (%) | 385 (22.4) | 19 (18.6) | 0.37 |
| Current drinker, n (%) | 384 (22.4) | 18 (17.6) | 0.26 |
| Proteinuria, n (%) | 1154 (67.3) | 67 (65.7) | 0.74 |
FPG: fasting plasma glucose; HbA1c: glycosylated haemoglobin A1c; BMI: body mass index; SBP: systolic blood pressure; DBP: diastolic blood pressure; BUN: blood urea nitrogen; BUA: blood uric acid; LDL: low-density lipoprotein; HDL: high-density lipoprotein.
Frequency of diabetic retinopathy (DR) and its pathological features in eyes with and without high myopia.
| Absence of high myopia (n, %) | High myopia (n, %) | ||
|---|---|---|---|
| DR | 664 (38.7) | 24 (23.5) | 0.002 |
| NPDR | 606 (35.3) | 23 (22.5) | 0.005 |
| PDR[ | 58 (3.4) | 1 (1.0) | 0.25 |
| MA and spot haemorrhage | |||
| None | 674 (39.3) | 53 (52.0) | 0.038 |
| Mild | 909 (53.0) | 42 (41.2) | |
| Severe | 132 (7.7) | 7 (6.9) | |
| Hard exudates | |||
| None | 1343 (78.3) | 90 (88.2) | 0.017 |
| Presence | 372 (21.7) | 12 (11.8) | |
| Cotton wool spot | |||
| None | 1479 (86.2) | 93 (91.2) | 0.16 |
| Presence | 236 (13.8) | 9 (8.8) | |
| IRMA[ | |||
| None | 1643 (95.8) | 102 (100.0) | 0.031 |
| Presence | 72 (4.2) | 0 (0.0) | |
| VB[ | |||
| None | 1692 (98.7) | 102 (100.0) | 0.66 |
| Presence | 23 (1.3) | 0 (0.0) | |
| DME | 215 (12.5) | 10 (9.8) | 0.42 |
| Non-CSME | 95 (5.5) | 5 (4.9) | 0.68 |
| CSME | 120 (7.0) | 5 (4.9) | |
NPDR: non-proliferative diabetic retinopathy; PDR: proliferative DR; MA: microaneurysm; IRMA: intraretinal microvascular abnormality; VB: venous beading; DME: diabetic macular edema; CSME: clinically significant macular edema.
Calculated by Fisher’s exact test, while others calculated by chi-square test.
Logistic regression analysis for the diabetic retinopathy (DR).
| Univariate OR (95% CI) | Multivariate OR (95% CI)[ | |
|---|---|---|
| High myopia (vs not high myopia) | ||
| DR | 0.49 (0.31–0.78) | 0.39 (0.22–0.68) |
| NPDR | 0.51 (0.32–0.82) | 0.40 (0.23–0.70) |
| PDR | 0.28 (0.04–2.06) | 0.33 (0.04–2.51) |
| Per 1 diopter increase | ||
| DR | 1.04 (1.00–1.07) | 1.08 (1.03–1.12) |
| NPDR | 1.04 (1.00–1.08) | 1.08 (1.03–1.13) |
| PDR | 1.00 (0.92–1.10) | 1.05 (0.93–1.19) |
OR: odds ratio; CI: confidence interval; NPDR: non-proliferative diabetic retinopathy; PDR: proliferative DR.
Adjusted for age, gender, income level, duration of diabetes mellitus, fasting plasma glucose, HbA1c, systolic blood pressure, total cholesterol, high-density lipoprotein and urine protein level.
Figure 1.Scatter plot between central retinal arteriolar/venular equivalent (CRAE, CRVE) and refractive error.
Association between CRAE/CRVE and high myopia/diopter.
| CRAE | CRVE | |||
|---|---|---|---|---|
| β (95% CI)[ | β (95% CI)[ | |||
| High myopia (vs not high myopia) | −18.8 (−22.3 to −15.2) | <0.001 | −37.1 (−42.3 to −31.8) | <0.001 |
| Per 1 diopter increase | 2.0 (1.7–2.3) | <0.001 | 4.3 (3.9–4.7) | <0.001 |
CRAE: central retinal arteriolar equivalent; CRVE: central retinal venular equivalent; CI: confidence interval.
Adjusted for age, gender, education level, income level, duration of diabetes mellitus, fasting plasma glucose, HbA1c, body mass index, systolic blood pressure, diastolic blood pressure, serum creatinine, blood uric acid, total triglycerides and high-density lipoprotein.
Logistic regression analysis for the diabetic retinopathy (DR).
| Univariate OR (95% CI) | Multivariate OR (95% CI)[ | |
|---|---|---|
| CRAE (per 10 μm increase) | ||
| DR | 1.08 (1.02–1.14) | 0.99 (0.92–1.07) |
| NPDR | 1.12 (1.06–1.19) | 1.02 (0.95–1.10) |
| PDR | 0.71 (0.61–0.82) | 0.67 (0.56–0.82) |
| CRVE (per 10 μm increase) | ||
| DR | 1.25 (1.20–1.30) | 1.24 (1.17–1.31) |
| NPDR | 1.26 (1.21–1.32) | 1.24 (1.18–1.31) |
| PDR | 1.01 (0.91–1.13) | 1.00 (0.87–1.15) |
OR: odds ratio; CI: confidence interval; CRAE: central retinal arteriolar equivalent; CRVE: central retinal venular equivalent; CI: confidence interval; NPDR: non-proliferative diabetic retinopathy; PDR: proliferative DR.
Adjusted for age, gender, spherical equivalent, income level, duration of diabetes mellitus, fasting plasma glucose, HbA1c, systolic blood pressure, total cholesterol, high-density lipoprotein and urine protein level.